November 30
PolyActiva Chief Strategy Officer Vanessa Waddell on Raising, Rejection, and the Road Ahead
Read more
Brandon BioCatalyst is the largest life science investment fund in Australia and New Zealand. We are a unique collaboration between major Australian superannuation funds, CSL, the Australian and New Zealand governments, Australian state governments and more than 50 leading medical research institutes and research hospitals.
Learn more about who we areA clinical stage company developing treatment for hot flashes in cancer survivors undergoing endocrine therapy
View ProjectDeveloping disease-modifying mitochondrial therapeutics for neurodegenerative disorders
View ProjectDeveloping the next generation of CAR-T cell therapies to treat solid cancers
View ProjectCombining non-opioid analgesics and biopolymers to deliver weeks of localised pain management
View ProjectUnlocking the potential of N-myristoyltransferase (NMT) to develop precision medicines for a range of diseases including cancer and viral infections
View ProjectGlyscend is developing novel non-absorbable polymers that are orally-delivered for the treatment of Type 2 Diabetes.
View ProjectThe Telethon Kids Research Institute is the largest research institute in Western Australia, with a bold vision to improve the health and development of children through excellence in research. Focused on translation, the Institute’s researchers and clinicians work closely, together with our research collaborators across Australia and around the world, to maximise research impact. They have extensive experience in coordinating technology and pharmaceutical interventions – including industry-sponsored trials – across a variety of diseases affecting children
ViewThe Ferrier Research Institute, Victoria University of Wellington, New Zealand is named after the late Professor Robin Ferrier who pioneered carbohydrate chemistry in New Zealand.
ViewThe ithree institute brings together a team of scientists with diverse skill sets who collectively address key challenges in the understanding and control of infectious diseases in humans and animals. Our senior scientists have recently refined the key research themes under which they will work together to increase their impact in the antibiotic resistance, food safety and infectious disease space.
ViewBrandon BioCatalyst is innovation in action: We provide a path for taking medical science from conception into the real world.
Our Venture capital model is unique. We don’t simply provide investment, we partner with entrepreneurs to create businesses, run companies and everything necessary to ensure our investments succeed.
Learn morePolyActiva Chief Strategy Officer Vanessa Waddell on Raising, Rejection, and the Road Ahead
Read moreScience: The World’s Shared Language That Carried One Founder Across Continents
Read moreENA Respiratory Attracts US$22.4m (AU$34m) to Fund Phase II Clinical Studies of INNA-051 Nasal Spray Designed to Protect Against Symptomatic Viral Respiratory Infections
Read moreBioMedTech Incubator Program Delivered by Brandon BioCatalyst’s CUREator and CSIRO Opens New Funding Round
Read more